Bexion Pharmaceuticals
Shabnam Kazmi is an experienced commercial leader in the oncology pharmaceutical and biotech industry with a track record of bringing innovative oncology products to patients and building asset value by successfully managing bench-to-bedside drug development and commercialization. She has held executive roles at Bristol-Myers Squibb, Sanofi and Otsuka, managing global businesses and joint ventures. Shabnam has played key roles in the launch of three top oncology brands across solid tumors and hematology, and an $860M acquisition, fundraising and an IPO.
This person is not in the org chart
This person is not in any offices
Bexion Pharmaceuticals
Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. Bexion focuses on helping patients and their families living with cancer, where there is a significant unmet need.